Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,958 total articles
KANZHUN LIMITED, operating as BOSS Zhipin and listed on Nasdaq (BZ), announced ongoing share repurchases in 2026, having bought back shares worth nearly RMB880 million so far this year. The recent repurchase of over RMB17.0 million for 349,516 shares on April 15 emphasizes the company's strong commitment to returning value to shareholders.
Bilibili Inc., a leading Chinese video community company, announced the filing of its annual report on Form 20-F for the fiscal year ending December 31, 2025, with the U.S. Securities and Exchange Commission. The report includes audited consolidated financial statements and is available online and by request to shareholders and ADS holders.
Transocean Ltd. announced a significant five-well contract award worth approximately $158 million for its Deepwater Asgard drillship to operate in the Eastern Mediterranean. The 390-day campaign is set to begin in Q4 2026 and adds to a total backlog increase of roughly $1.6 billion in April. This contract reinforces Transocean's leadership in ultra…
Remitly Global, Inc. has introduced its app on the ChatGPT platform, becoming the first cross-border money transfer company to do so. This integration allows users to explore exchange rates and delivery options directly within ChatGPT, streamlining the process for customers in the US, Canada, and the UK before completing transfers on Remitly's app …
Aclarion, Inc., a healthcare technology company, has secured a U.S. patent (#12,601,803) for its AI-driven machine learning platform that analyzes magnetic resonance spectroscopy data to help physicians identify chronic low back pain sources. This strengthens their cloud-based Nociscan platform by protecting AI applications that automate biomarker …
DT Midstream, Inc. announced it will release its first quarter 2026 financial results on April 30, 2026, before the market opens. The company has scheduled a conference call to discuss the results the same morning, with live webcast access provided for investors and the public.
Kailera Therapeutics, a clinical-stage biotech company specializing in advanced obesity treatments, announced the pricing of its IPO at $16 per share, expected to raise approximately $625 million before expenses. The company plans to list its common stock on Nasdaq under the ticker KLRA on April 17, 2026. The funds raised aim to support Kailera's c…
Bilibili Inc., a leading Chinese video community platform, has published its 2025 Environmental, Social and Governance (ESG) Report. The report details the company's progress in adopting sustainable and responsible business practices, aiming to create value for users, creators, employees, partners, and the broader community. The report is available…
Manhattan Bridge Capital, Inc. reported a slight decrease in net income for Q1 2026 compared to the same period in 2025, with net income of approximately $1.27 million down 7.2% primarily due to lower revenue from reduced loan origination activity and loan receivables. Despite this, the company saw reduced interest expenses and an encouraging level…
Kaspi.kz held its Annual General Meeting on April 15, 2026, approving the 2025 audited financial statements, a dividend of 850 KZT per common share, and reappointing Deloitte LLP as external auditor. The company also approved stock option awards as part of long-term incentives for Board Members.
Radiopharm Theranostics announced the completion of patient enrollment in their U.S. Phase 2b imaging trial for RAD 101, a novel imaging agent targeting fatty acid synthase for detecting recurrent brain metastases. Interim data shows 90% concordance with MRI, with full data anticipated in June 2026. The company plans to advance RAD 101 into a Phase…
Balchem Corporation will release its first quarter 2026 financial results before the market opens on April 30, 2026, followed by a conference call hosted by its CEO and CFO to discuss the results. Balchem operates in three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, delivering specialty ingredients globall…
Brookfield Corporation announced the pricing of C$500 million medium-term notes due 2036 and a C$250 million re-opening of its existing medium-term notes due 2055. The notes offer attractive yields and carry solid investment-grade credit ratings. Proceeds will be utilized for general corporate purposes, reflecting ongoing strategic financing activi…
MeiraGTx announced positive three-year data from its Phase 1 AQUAx study evaluating AAV-hAQP1 gene therapy for grade 2/3 late radiation-induced xerostomia. The data show sustained clinical improvements in patient-reported symptoms and increased saliva flow rates, with the therapy demonstrating a strong safety profile. This durable, one-time treatme…
Harrow announced that the FDA-approved ophthalmic drug IOPIDINE® 1% has received a permanent J-Code (J2374) by CMS, effective July 1, 2026. The J-Code enables physicians to receive reimbursement for administrating IOPIDINE 1% during in-office procedures to prevent intraocular pressure spikes, a common complication of glaucoma-related laser surgerie…
Aurora Mobile Limited (NASDAQ: JG) showcased its AI-driven customer engagement platform, EngageLab, at InnoEX Hong Kong, introducing innovative solutions to streamline omnichannel communication, reduce integration complexity, and enhance AI-powered customer support. EngageLab demonstrated intelligent fallback workflows, agile customization via deve…
Adlai Nortye Ltd., a clinical-stage biotechnology company specializing in cancer therapies, announced a $150 million private investment in public equity financing. The oversubscribed placement involved new and existing institutional investors purchasing 11.3 million ADSs at $13.25 each, matching the closing Nasdaq price. The funds aim to support th…
Metagenomi Therapeutics, Inc. (Nasdaq: MGX) announced a scientific publication highlighting MG119-28, a proprietary compact CRISPR nuclease with superior genome editing efficiency compared to previously known nucleases. The research demonstrates structural and mechanistic features that improve editing in mammalian cells, supporting the company's pi…
Eton Pharmaceuticals announced that Judith M. Matthews will become its Chief Financial Officer starting June 1, 2026, succeeding current CFO James Gruber who will transition out after a consulting period. Matthews brings over 25 years of finance leadership in pharmaceutical companies, aiming to support Eton's growth and rare disease portfolio expan…
Canadian National Railway Company (CN) announced a $500,000 donation to two Winnipeg-based organizations to support programs aimed at preventing homelessness, especially among Indigenous youth and vulnerable populations. The funding is part of CN's Railroaders for Change initiative to enhance safety and well-being in communities near its operations…
MeiraGTx Holdings plc has entered into an asset purchase agreement with Johnson & Johnson to acquire all interests in botaretigene sparoparvovec (bota-vec), a gene therapy for X-linked Retinitis Pigmentosa (XLRP). With strong Phase 3 trial data supporting clinically meaningful vision improvements in patients with no current treatment options, Meira…
Holley Performance Brands (NYSE: HLLY) announced the launch of Cataclean Diesel Exhaust System & DPF Cleaner, a diesel-specific emissions treatment designed to improve diesel engine performance and emissions system efficiency. This new product expands Cataclean's market reach into diesel vehicles, supporting Holley's broader American Performance ch…
JD.com, a leading supply chain-based technology and service provider, has filed its annual report on Form 20-F with the SEC for the fiscal year ended December 31, 2025. The company also published a substantially similar annual report in Hong Kong as required by HKEx. These reports provide audited consolidated financial statements and detail JD.com'…
Helus Pharma, a clinical stage pharmaceutical company developing novel serotonergic agonists (NSAs) for mental health conditions, announced the appointment of Dr. Ken Kramer as Senior Vice President, Medical Affairs. Dr. Kramer brings over 25 years of neuroscience and medical launch experience, including leadership roles at Bristol Myers Squibb and…
Xilio Therapeutics, a clinical-stage biotech company focused on developing masked immuno-oncology therapies, announced the appointment of Cheryl R. Blanchard, Ph.D., a seasoned leader in life sciences, to its board of directors. Dr. Blanchard’s extensive experience in biologics, small molecules, and medical devices will support Xilio's advancement …
